MediMabs Antibodies is a biotech company established in 2006 in Montreal, Quebec by a group of McGill University researchers. The company was founded with the mission of providing affordable access to high-quality research antibodies for local researchers. Offering custom antibody generation services and aiming to deliver a solution that is faster, better, and more cost-effective than in-house research laboratories, MediMabs Antibodies has positioned itself in the heart of Montreal's life science cluster, surrounded by various biotech companies, universities, R&D institutions, major healthcare networks, and hospitals. The company has continually evolved, now providing innovative services and serving as a comprehensive "One stop shop" for all antibody needs. Presently, there is no data available regarding the last investment and the investors involved. The company operates within the biopharma, biotechnology, and healthcare industries.
There is no investment information
No recent news or press coverage available for MediMabs Antibodies.
We care about your data, and we'd love to use cookies make your experience better.
